Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries
Condition(s) studied
Investigational drug(s) / intervention(s)
Atherectomy: Two different techniques : rotational atherectomy or thromboendarterectomy
Study summary
Thromboendarterectomy is the standard technique for the treatment of symptomatic occlusive lesions of the common femoral artery. It consists of surgically controlling the artery and interrupting circulation, opening the vessel and removing the atherosclerotic plaque. However, this technique is associated with healing difficulties, postoperative infections, and debilitating incisional pain. The rise of endovascular therapies, particularly at the coronary level, has led to the emergence of new deocclusion techniques, including rotational atherectomy. This technique relies on the use of an intravascular catheter that reams out the atherosclerotic plaque while re-aspirating the resulting debris. A few studies have examined the use of rotational atherectomy for occlusive lesions of the common femoral arteries, but have not evaluated its results compared to the standard treatment. The aim of this multicenter cohort is to describe the efficacy and safety of rotational atherectomy and the standard treatment, thromboendarterectomy, in symptomatic occlusive lesions affecting the common femoral artery.
Eligibility
Primary outcome measure(s)
- Local complications — one month
Local complications are defined as follows: hematoma, active bleeding, local infection, thrombosis, delayed healing, false aneurysm, arteriovenous fistula, and neuropathic pain following surgical trauma.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Privé de Villeneuve d'Ascq, | Villeneuve-d'Ascq | France |
More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07142330 on ClinicalTrials.gov ↗ ← All trials in France